Standout Papers

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanc... 2004 2026 2011 2018 2.9k
  1. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (2007)
    Malcolm J. Moore, David Goldstein et al. Journal of Clinical Oncology
  2. Pancreatic cancer (2004)
    Donghui Li, Keping Xie et al. The Lancet
  3. Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer (2008)
    Navneet K. Dhillon, Bharat B. Aggarwal et al. Clinical Cancer Research
  4. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy (2006)
    Gauri R. Varadhachary, Eric P. Tamm et al. Annals of Surgical Oncology
  5. Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease (2008)
    Matthew H. G. Katz, Peter W. T. Pisters et al. Journal of the American College of Surgeons
  6. Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head (2008)
    Douglas B. Evans, Gauri R. Varadhachary et al. Journal of Clinical Oncology
  7. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group (2020)
    Humaid O. Al‐Shamsi, Waleed Alhazzani et al. The Oncologist
  8. Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers (2019)
    Rachna T. Shroff, Milind Javle et al. JAMA Oncology

Immediate Impact

7 by Nobel laureates 5 from Science/Nature 121 standout
Sub-graph 1 of 17

Citing Papers

Pancreatic cancer
2025 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
58 intermediate papers

Works of Robert A. Wolff being referenced

Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants
2021
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
and 37 more

Author Peers

Author Last Decade Papers Cites
Robert A. Wolff 21227 9068 6065 8251 455 28.2k
Olivier Bouché 18148 7789 4361 9242 410 24.6k
James L. Abbruzzese 25539 7792 10406 8411 507 42.6k
Richard D. Schulick 19325 16967 3214 10328 334 31.9k
John P. Neoptolemos 27654 21155 6322 11698 507 39.3k
Marc Ychou 15774 4736 5031 7558 319 21.6k
Al B. Benson 18591 8507 5438 8504 487 30.3k
Malcolm J. Moore 24529 9275 7199 10385 354 36.2k
Michel Ducreux 25207 11207 5229 10305 612 36.6k
Filippo de Braud 17473 5482 3589 8522 749 26.0k
Jean‐Pierre Pignon 14491 8696 2725 15967 305 30.3k

All Works

Loading papers...

Rankless by CCL
2026